These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20191188)

  • 1. [Hidradenitis suppurativa treated with infliximab].
    Obadia DL; Daxbacher EL; Jeunon T; Gripp AC
    An Bras Dermatol; 2009; 84(6):695-7. PubMed ID: 20191188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
    Montes-Romero JA; Callejas-Rubio JL; Sánchez-Cano D; González-Martínez FJ; Navas-Parejo A; Ortego-Centeno N
    Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
    Moschella SL
    Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
    Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
    Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
    Delage M; Samimi M; Atlan M; Machet L; Lorette G; Maruani A
    Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hidradenitis suppurativa. Response to treatment with infliximab].
    Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
    Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with hidradenitis suppurativa.
    Martorell A; Caballero A; González Lama Y; Jiménez-Gallo D; Lázaro Serrano M; Miranda J; Pascual JC; Salgado-Boquete L; Marín-Jiménez I
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():32-42. PubMed ID: 28081768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association and management of Crohn's disease plus hidradenitis suppurativa.
    dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
    Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
    Arenbergerova M; Gkalpakiotis S; Arenberger P
    Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease and hidradenitis suppurativa. An uncommon association that responds to infliximab.
    Blazquez I; Gonzalez-Lama Y; Roustan G
    J Crohns Colitis; 2013 Dec; 7(12):e717-8. PubMed ID: 24080248
    [No Abstract]   [Full Text] [Related]  

  • 15. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Ingram JR; Burton T
    Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of recalcitrant hidradenitis suppurativa with ustekinumab.
    Sharon VR; Garcia MS; Bagheri S; Goodarzi H; Yang C; Ono Y; Maverakis E
    Acta Derm Venereol; 2012 May; 92(3):320-1. PubMed ID: 22101775
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hidradenitis suppurativa with infliximab.
    Torres T; Selores M
    An Bras Dermatol; 2010; 85(4):576. PubMed ID: 20944927
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.
    Koilakou S; Karapiperis D; Tzathas C
    Am J Gastroenterol; 2010 Jan; 105(1):231-2. PubMed ID: 20054324
    [No Abstract]   [Full Text] [Related]  

  • 19. Variable response of hidradenitis suppurativa to infliximab in four patients.
    Usmani N; Clayton TH; Everett S; Goodfield MD
    Clin Exp Dermatol; 2007 Mar; 32(2):204-5. PubMed ID: 17342798
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab for the treatment of hidradenitis suppurativa.
    Lebwohl B; Sapadin AN
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S275-6. PubMed ID: 14576652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.